Akebia Therapeutics Inc (NAS:AKBA) Stock News, Headlines & Updates
Akebia Therapeutics Inc Stock News from GuruFocus
- 1
Aug 26, 2024
Akebia Therapeutics to Present at Upcoming Investor Conferences
PRNewswire • 8:00am
Aug 08, 2024
Akebia Therapeutics Inc (AKBA) Q2 2024 Earnings: EPS Misses, Revenue Falls Short at $43.6 Million
GuruFocus Research • 6:38am
Akebia Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
PRNewswire • 6:00am
Aug 02, 2024
Akebia Therapeutics to Report Second Quarter 2024 Financial Results and Discuss Recent Business Highlights
PRNewswire • 8:00am
Aug 01, 2024
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PRNewswire • 4:00pm
Jul 29, 2024
Akebia Therapeutics to Present at Upcoming Investor Conferences
PRNewswire • 8:00am
Jul 11, 2024
Akebia Therapeutics Provides Update on Continued Momentum of Commercial Launch of Vafseo® (vadadustat) Tablets
PRNewswire • 6:00am
Jul 01, 2024
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PRNewswire • 4:00pm
Jun 27, 2024
Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference
PRNewswire • 8:00am
Jun 24, 2024
Akebia Therapeutics Appoints Erik Ostrowski as Chief Financial Officer and Chief Business Officer
PRNewswire • 8:00am
Jun 03, 2024
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PRNewswire • 4:00pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news